Otsuka Holdings
4578.T
$36.09
Share price
-2.13%
Change (1 day)
5.13%
Change (1 year)
Categories
Otsuka Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company involved in the R&D of drugs and healing methods for respiratory diseases, eye diseases, cardiovascular diseases, neurological and mental diseases as well as Parkinson's, tuberculosis and cancer.
P/S ratio for Otsuka Holdings (4578.T)
P/S ratio as of September 2023 (TTM): 1.48
According to Otsuka Holdings 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.47678. At the end of 2023 the company had a P/S ratio of 1.46.
P/S ratio history for Otsuka Holdings from 2010 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 1.46 | 8.74% |
| 2022 | 1.34 | -8.76% |
| 2021 | 1.47 | -15.18% |
| 2020 | 1.73 | -8.77% |
| 2019 | 1.90 | 0.74% |
| 2018 | 1.88 | -12.4% |
| 2017 | 2.15 | -0.31% |
| 2016 | 2.16 | 33% |
| 2015 | 1.62 | 27.71% |
| 2014 | 1.27 | 12.8% |
| 2013 | 1.13 | 2.01% |
| 2012 | 1.10 | 1.69% |
| 2011 | 1.09 | 18.51% |
| 2010 | 0.9160 |